EDAP will pay interest in shares on 9% senior convertibles due 2012

By Devika Patel

Knoxville, Tenn., June 6 - EDAP TMS SA announced in a prospectus supplement filed Friday with the Securities and Exchange Commission that it intends to pay interest on its 9% senior convertible debentures due 2012 in common shares, rather than cash, effective July 1.

From now on, unless the company issues a revised notice, all future interest payments on the debentures will be in stock.

Based in Lyon, France, EDAP focuses on its Ablatherm product, a high-intensity focused ultrasound treatment for prostate cancer.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.